Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Natalie Böhm"'
Autor:
Jennifer Preston, Natalie Bohm, Adit Bassi, Angela Davies, Kamil Sterniczuk, Berkeley Phillips, Sally-Anne Dews, Sean Buckland, Lucy Clements, Rachel Daley, Sophie Evett, Samantha Howland, Emma Kinloch, Gareth Powell
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Objectives Patient and public involvement (PPI) in clinical research has a well-established infrastructure in the UK, and while there has been good progress within pharmaceutical-industry-sponsored research, further improvements are still needed. Thi
Externí odkaz:
https://doaj.org/article/52fba11a97d74cb9ad889632a1e7f0e7
Autor:
Klaus Aktories, Katharina Ernst, Natalie Böhm, Michel R. Popoff, Simon Langer, Holger Barth, Carsten Schwan, Gunter Fischer, Eva Kaiser
Publikováno v:
Cellular Microbiology
Cellular Microbiology, Wiley, 2012, 14 (8), pp.1193-1205. ⟨10.1111/j.1462-5822.2012.01788.x⟩
Cellular Microbiology, Wiley, 2012, 14 (8), pp.1193-1205. 〈10.1111/j.1462-5822.2012.01788.x〉
Cellular Microbiology, 2012, 14 (8), pp.1193-1205. ⟨10.1111/j.1462-5822.2012.01788.x⟩
Cellular Microbiology, Wiley, 2012, 14 (8), pp.1193-1205. ⟨10.1111/j.1462-5822.2012.01788.x⟩
Cellular Microbiology, Wiley, 2012, 14 (8), pp.1193-1205. 〈10.1111/j.1462-5822.2012.01788.x〉
Cellular Microbiology, 2012, 14 (8), pp.1193-1205. ⟨10.1111/j.1462-5822.2012.01788.x⟩
International audience; The binary Clostridium botulinum C2 toxin consists of the binding/translocation component C2IIa and the separate enzyme component C2I. C2IIa delivers C2I into the cytosol of eukaryotic target cells where C2I ADP-ribosylates ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232049c54ee0d27ab7a0671407f6cdf8
https://hal-pasteur.archives-ouvertes.fr/pasteur-01762818
https://hal-pasteur.archives-ouvertes.fr/pasteur-01762818
Autor:
Joseph C Cappelleri, Matthew J Brookes, Natalie Bohm, John Waller, Irene Modesto, Marco D DiBonaventura, Ruth Mokgokong, Danielle Bargo
Publikováno v:
BMJ Open Gastroenterology, Vol 7, Iss 1 (2020)
Objective Ulcerative colitis (UC) is a lifelong, relapsing-remitting disease. Patients non-responsive to pharmacological treatment may require a colectomy. We estimated pre-colectomy and post-colectomy healthcare resource utilisation (HCRU) and costs
Externí odkaz:
https://doaj.org/article/c5d9c17e64254fdcb9025b0823da3aa2
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Heart failure with preserved ejection fraction (HFpEF) is a public health epidemic that is projected to double over the next two decades. Despite the high prevalence of HFpEF, there are currently no FDA approved therapies for health-related outcomes
Externí odkaz:
https://doaj.org/article/f804a0ec57484b919ab0accec2296537
Autor:
Anson M. Blanks, Thomas T. Wagamon, Lindsay Lafratta, Mabel G. Sisk, Morgan B. Senter, Lauren N. Pedersen, Natalie Bohmke, Attiya Shah, Virginia L. Mihalick, R. Lee Franco
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 2, Iss , Pp 100033- (2020)
Coronary artery disease (CAD) is an immune-mediated disease in which CCR2 attracts classical, intermediate, and non-classical monocytes to the arterial intima where they differentiate to macrophages. Balance between pro-inflammatory M1 and anti-infla
Externí odkaz:
https://doaj.org/article/1eb46f0b8e9e4ccd854fd3eb19772333
Autor:
Emily Wright, Christoph Lohan, Alex Diamantopoulos, Corinne LeReun, Natalie Bohm, Laura Marie Sawyer
Publikováno v:
BMJ Open Gastroenterology, Vol 6, Iss 1 (2019)
Background and aims In the UK, treatments for patients with moderately to severely active ulcerative colitis who have an inadequate response to conventional therapies comprise four biological therapies—the tumour necrosis factor inhibitor (TNFi) ag
Externí odkaz:
https://doaj.org/article/1f1ecced7b13469b8d58ece1b71d353f